Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ADTX

Aditxt (ADTX)

Aditxt Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADTX
DateTimeSourceHeadlineSymbolCompany
04/05/202404:14Business WireCORRECTING and REPLACING Aditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
03/05/202423:00Business WireAditxt Announces Pricing of $4.2 Million Private Placement Priced At-The-Market under Nasdaq RulesNASDAQ:ADTXAditxt Inc
02/04/202423:30Business WireAditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)NASDAQ:ADTXAditxt Inc
27/03/202423:36PR Newswire (US)Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023NASDAQ:ADTXAditxt Inc
12/03/202407:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
07/03/202423:54PR Newswire (US)For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended PregnancyNASDAQ:ADTXAditxt Inc
05/03/202409:27Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
05/03/202409:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/03/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
01/03/202408:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
23/02/202409:21Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:ADTXAditxt Inc
22/02/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
17/02/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
16/02/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
15/02/202401:26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ADTXAditxt Inc
10/02/202408:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
07/02/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
03/02/202408:28Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
03/02/202408:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
02/02/202400:00PR Newswire (US)Evofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023NASDAQ:ADTXAditxt Inc
31/01/202409:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
31/01/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
31/01/202400:30Business WireAditxt, Inc. Acquires Proprietary Electroencephalography (EEG) Brain Monitoring Technologies and Devices, Including NeuroCap™ and NeuroEEG™ for Telehealth and Tele-neurology ApplicationsNASDAQ:ADTXAditxt Inc
24/01/202408:18Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ADTXAditxt Inc
20/01/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
19/01/202408:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ADTXAditxt Inc
10/01/202409:19Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:ADTXAditxt Inc
10/01/202409:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
09/01/202400:30Business WireAditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life Sciences Inc.’s Proprietary Mitomic™ Testing Platform Pioneering Early Disease and Cancer Detection in a Transaction Valued at Approximately $25 MillionNASDAQ:ADTXAditxt Inc
06/01/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADTXAditxt Inc
 Showing the most relevant articles for your search:NASDAQ:ADTX